Literature DB >> 9415661

Cyclophosphamide induced water intoxication in a woman with Sjögren's syndrome.

A Spital1, S Ristow.   

Abstract

Water intoxication is a well described complication of high dose intravenous (i.v.) cyclophosphamide therapy combined with forced hydration. Less well known is that water intoxication can develop even after low dose iv cyclophosphamide. To draw attention to this potentially life threatening complication, we describe a woman who developed acute water intoxication after treatment with low dose iv cyclophosphamide for a sensory neuropathy secondary to Sjögren's syndrome. Rheumatologists should be aware of this serious adverse effect of iv cyclophosphamide because this drug is being used increasingly for treatment of a variety of rheumatological diseases. The pathogenesis, clinical characteristics, treatment, and methods for prevention of cyclophosphamide induced water intoxication are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415661

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Water intoxication induced by low-dose oral cyclophosphamide in a patient with anti-neutrophil cytoplasmic antibody-related glomerulonephritis.

Authors:  Akihiko Kato; Takeshi Sugiura; Tatsuo Yamamoto; Taro Misaki; Takayuki Tsuji; Yukitoshi Sakao; Masaaki Sakakima; Hideo Yasuda; Yoshihide Fujigaki; Akira Hishida
Journal:  NDT Plus       Date:  2008-10

2.  Water intoxication following low-dose intravenous cyclophosphamide.

Authors:  Tai Yeon Koo; Sang-Cheol Bae; Joon Sung Park; Chang Hwa Lee; Moon Hyang Park; Chong Myung Kang; Gheun-Ho Kim
Journal:  Electrolyte Blood Press       Date:  2007-06-30

3.  Cyclophosphamide-induced symptomatic hyponatremia, a rare but severe side effect: a case report.

Authors:  Shereen Elazzazy; Asmaa Elhassan Mohamed; Amaal Gulied
Journal:  Onco Targets Ther       Date:  2014-09-30       Impact factor: 4.147

4.  Symptomatic hyponatremia induced by low-dose cyclophosphamide in patient with systemic lupus erythematosus: A case report.

Authors:  Jiali Chen; Yuebo Jin; Chun Li; Zhanguo Li
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.